Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126244811 | 12624481 | 1 | I | 2002 | 20160708 | 20160805 | 20160805 | PER | US-ASTRAZENECA-2016SE75665 | ASTRAZENECA | 41.00 | YR | M | Y | 140.60000 | KG | 20160805 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126244811 | 12624481 | 1 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | |||||||||||
| 126244811 | 12624481 | 2 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | Q12H | |||||||
| 126244811 | 12624481 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | |||||||||||
| 126244811 | 12624481 | 4 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 126244811 | 12624481 | 5 | C | LOW-DOSE ASPIRIN | ASPIRIN | 1 | 0 | ||||||||||||
| 126244811 | 12624481 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 126244811 | 12624481 | 7 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126244811 | 12624481 | 8 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 0 | ||||||||||||
| 126244811 | 12624481 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126244811 | 12624481 | 10 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 0 | ||||||||||||
| 126244811 | 12624481 | 11 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 126244811 | 12624481 | 12 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 126244811 | 12624481 | 13 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 126244811 | 12624481 | 14 | C | NOVOLOG | INSULIN ASPART | 1 | 0 | ||||||||||||
| 126244811 | 12624481 | 15 | C | B100 VITAMIN | 2 | 0 | |||||||||||||
| 126244811 | 12624481 | 16 | C | METANX | LEVOMEFOLATE CALCIUMMETHYLCOBALAMINPYRIDOXAL PHOSPHATE ANHYDROUS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126244811 | 12624481 | 1 | Blood pressure abnormal |
| 126244811 | 12624481 | 2 | Type 2 diabetes mellitus |
| 126244811 | 12624481 | 3 | Gastrooesophageal reflux disease |
| 126244811 | 12624481 | 4 | Sleep apnoea syndrome |
| 126244811 | 12624481 | 5 | Anticoagulant therapy |
| 126244811 | 12624481 | 7 | Vertigo |
| 126244811 | 12624481 | 9 | Diabetes mellitus |
| 126244811 | 12624481 | 10 | Diabetes mellitus |
| 126244811 | 12624481 | 11 | Back pain |
| 126244811 | 12624481 | 12 | Neuropathy peripheral |
| 126244811 | 12624481 | 14 | Diabetes mellitus |
| 126244811 | 12624481 | 15 | Neuropathy peripheral |
| 126244811 | 12624481 | 16 | Neuropathy peripheral |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126244811 | 12624481 | Circumstance or information capable of leading to medication error | |
| 126244811 | 12624481 | Drug dose omission | |
| 126244811 | 12624481 | Neuropathy peripheral | |
| 126244811 | 12624481 | Sleep apnoea syndrome | |
| 126244811 | 12624481 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126244811 | 12624481 | 2 | 2002 | 0 |